Society · en
GLP-1 drugs are driving higher sales for Eli Lilly and Novo Nordisk
Sales of Mounjaro, Eli Lilly’s diabetes drug, rose 91 per cent in the second quarter of the year to US$9.94 billion, well above analysts' expectations.
Related index pages
Technology · TechCrunchShopify says AI search is driving more traffic and sales, not replacing Google
Shopify says AI isn’t cannibalizing search traffic the way it has for publishers. Instead, AI-driven traffic and orders to Shopify stores tripled year over year in Q2.Read original ↗
World · Nikkei AsiaDaikin posts higher profit on AC sales driven by European heat waves
OSAKA -- Daikin Industries grew operating profit by 8% on the year to a new record for the April-June quarter, expanding its market share in the AmeriRead original ↗
Society · The WalrusDoug Ford and Danielle Smith Are Teaming Up to Build a Pipeline
The premiers are betting Canadians have changed their minds about climate change The post Doug Ford and Danielle Smith Are Teaming Up to Build a Pipeline first appeared on The…Read original ↗
Society · The WalrusChinese Spies Are Recruiting Canadians on LinkedIn
Networking sites are the latest front in Beijing’s espionage campaign The post Chinese Spies Are Recruiting Canadians on LinkedIn first appeared on The Walrus .Read original ↗
Society · NPRThese are some of the last pristine ocean ecosystems. Now, they're losing protections
The largest conservation areas in the U.S. are in the Pacific Ocean, where tiny islands are epicenters of biodiversity.…Read original ↗
Society · Global News